Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease

Clinical Epigenetics

Volumn 7, Issue 1, 2015, Pages

  Zeybel, Müjdat ^a   Hardy, Timothy ^a   Robinson, Stuart M ^a   Fox, Christopher ^a   Anstee, Quentin M ^a   Ness, Thomas ^b   Masson, Steven ^a   Mathers, John C ^a   French, Jeremy ^a   White, Steve ^a   Mann, Jelena ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

ALD; DNA methylation; Epigenetics; NAFLD; Pyrosequencing

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; INSULIN; IRINOTECAN; ORAL ANTIDIABETIC AGENT; OXALIPLATIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGE; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CLINICAL ARTICLE; COLLAGEN 1A1 GENE; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; CPG ISLAND; DISEASE COURSE; DISEASE SEVERITY; DNA ISOLATION; DNA METHYLATION; DNA SEQUENCE; DYSLIPIDEMIA; FEMALE; FIBROGENESIS; GENDER; GENE; GENE FUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; LIVER BIOPSY; LIVER FIBROSIS; MALE; MOLECULAR PATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PATHOLOGICAL ANATOMY; PDGFALPHA GENE; PPARALPHA GENE; PRIORITY JOURNAL; PYROSEQUENCING; TGFBETA1 GENE;

EID: 84969179560     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/s13148-015-0056-6     Document Type: Article

References (25)

1. Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol. 2003;38 Suppl 1:S38-53.
2. Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425-56.
3. Anstee QM, Daly AK, Day CP. Genetics of alcoholic and nonalcoholic fatty liver disease. Semin Liver Dis. 2011;31:128-46.
4. Anstee QM, Day CP. The genetics of NAFLD. Nat Rev Gastroenterol Hepatol. 2013;10:645-55.
5. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010;28:1057-68.
6. Mathers JC, Strathdee G, Relton CL. Induction of epigenetic alterations by dietary and other environmental factors. Adv Genet. 2010;71:3-39
7. Mathers JC. Session 2: personalised nutrition. Epigenomics: a basis for understanding individual differences? Proc Nutr Soc. 2008;67:390-4
8. Meissner A. Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol. 2010;28:1079-88.
9. Illingworth RS, Bird AP. CpG islands - ‘a rough guide’. FEBS Lett. 2009;583:1713-20.
10. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16:6-21.
11. Bergman Y, Cedar H. DNA methylation dynamics in health and disease. Nat Struct Mol Biol. 2013;20:274-81.
12. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009;41:178-86.
13. Murphy SK, Yang H, Moylan CA, Pang H, Dellinger A, Abdelmalek MF, et al. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. Gastroenterology. 2013;145:1076-87.
14. Sookoian S, Rosselli MS, Gemma C, Burgueño AL, Fernández Gianotti T, Castaño GO, et al. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor gamma coactivator 1alpha promoter. Hepatology. 2010;52:1992-2000.
15. Cordero P, Campion J, Milagro FI, Goyenechea E, Steemburgo T, Javierre BM, et al. Leptin and TNF-alpha promoter methylation levels measured by MSP could predict the response to a low-calorie diet. J Physiol Biochem. 2011;67:463-70.
16. Zeybel M, Hardy T, Wong YK, Mathers JC, Fox CR, Gackowska A, et al. Multigenerational epigenetic adaptation of the hepatic wound-healing response. Nat Med. 2012;18:1369-77.
17. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128:1898-906.
18. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33 (Suppl):245-54.
19. Bian EB, Huang C, Wang H, Wu BM, Zhang L, Lv XW, et al. DNA methylation: new therapeutic implications for hepatic fibrosis. Cell Signal. 2013;25:355-8.
20. Nishida N, Kudo M, Nagasaka T, Ikai I, Goel A. Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma. Hepatology. 2012;56:994-1003.
21. Waterland RA, Travisano M, Tahiliani KG, Rached MT, Mirza S. Methyl donor supplementation prevents transgenerational amplification of obesity. Int J Obes (Lond). 2008;32:1373-9.
22. Cordero P, Gomez-Uriz AM, Campion J, Milagro FI, Martinez JA. Dietary supplementation with methyl donors reduces fatty liver and modifies the fatty acid synthase DNA methylation profile in rats fed an obesogenic diet. Genes Nutr. 2013;8:105-13.
23. McKay JA, Xie L, Manus C, Langie SA, Maxwell RJ, Ford D, et al. Metabolic effects of a high-fat diet post-weaning after low maternal dietary folate during pregnancy and lactation. Mol Nutr Food Res. 2014;58:1087-97.
24. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-21.
25. MacSween RN, Burt AD. Histologic spectrum of alcoholic liver disease. Semin Liver Dis. 1986;6:221-32.